Lexaria Bioscience Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Lexaria Bioscience Corp. generated cash of -$4,959,003, which is more than the previous year. Cash used in financing activities reached the amount of $10,315,207 last year. Net change in cash is therefore $5,147,783.
Cash Flow
| 2015 | -1.50M | 684.81K | 373.25K |
|---|---|---|---|
| 2016 | -660.85K | -20.10K | 514.29K |
| 2017 | -1.54M | -9.69K | 3.99M |
| 2018 | -2.51M | -155.39K | 1.86M |
| 2019 | -3.00M | -769.16K | 3.33M |
| 2020 | -2.66M | -26.84K | 2.69M |
| 2021 | -3.98M | 193.88K | 13.41M |
| 2022 | -4.87M | -180.64K | -44.6K |
| 2023 | -5.88M | -169.61K | 1.58M |
| 2024 | -4.95M | -188.60K | 10.31M |
LEXXW Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.35M | 5.81M | 10.91M | 1.29M | 1.28M | 1.72M | 2.53M | 93.40K | 260.07K | 703.03K |
Operating activities | ||||||||||
Net income | -5.80M | -6.71M | -7.38M | -4.18M | -4.08M | -4.15M | -6.60M | -1.92M | -1.27M | -1.93M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 76.15K | 145.39K | 141.31K | 147.59K | 112.75K | 60.55K | 2.30K | 1.48K | 619 | 0 |
Stock-based compensation expense | 492.23K | 170.38K | 752.59K | 410.00K | 1.13M | 626.69K | 2.60M | 113.04K | 122.01K | 256.05K |
| Deferred income tax benefit | 492.23K | 170.38K | 752.59K | 410.00K | 1.13M | 626.69K | 2.60M | 113.04K | 122.01K | 256.05K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -35.55K | 26.53K | -137.49K | 189.58K | -90.78K | -138.64K | -324.33K | -7.71K | -6.20K | 65.62K |
Inventories | 0 | 43.06K | -1.97K | 95.03K | 4.21K | -47.34K | -33.02K | -1.06K | -10.77K | -167.98K |
Accounts payable | 826.46K | 88.49K | 50.72K | 13.80K | -49.49K | 100.62K | 3.21K | -40.43K | 56.93K | -60.48K |
Cash generated by operating activities | -4.95M | -5.88M | -4.87M | -3.98M | -2.66M | -3.00M | -2.51M | -1.54M | -660.85K | -1.50M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -33.74K | -131.44K | -79.49K | -33.64K | -769.16K | -85.39K | -9.69K | -20.10K | -36.98K |
Acquisitions Net | 0 | 0 | 0 | 273.37K | 0 | 0 | -70K | 0 | 0 | 0 |
Cash generated by investing activities | -188.60K | -169.61K | -180.64K | 193.88K | -26.84K | -769.16K | -155.39K | -9.69K | -20.10K | 684.81K |
Financing activities | ||||||||||
Common Stock Issued | 4.20M | 1.58M | 0 | 9.47M | 2.66M | 2.33M | 1.86M | 4.04M | 419.29K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -66.69K | -44.49K | 0 | -34.83K | -50K | -95K | -98.74K |
Cash used in financing activities | 10.31M | 1.58M | -44.6K | 13.41M | 2.69M | 3.33M | 1.86M | 3.99M | 514.29K | 373.25K |
Net Change In Cash | 5.14M | -4.46M | -5.10M | 9.62M | 8.60K | -442.03K | -806.15K | 2.43M | -166.66K | -442.95K |
Cash at end of period | 6.49M | 1.35M | 5.81M | 10.91M | 1.29M | 1.28M | 1.72M | 2.53M | 93.40K | 260.07K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |